PACS Group, Inc. (NYSE:PACS – Get Free Report) Director Mark Hancock sold 186,696 shares of PACS Group stock in a transaction dated Wednesday, November 4th. The stock was sold at an average price of $50.45, for a total value of $9,418,813.20. Following the sale, the director directly owned 53,318,884 shares in the company, valued at approximately $2,689,937,697.80. The trade was a 0.35% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Mark Hancock also recently made the following trade(s):
- On Thursday, October 29th, Mark Hancock sold 4,280 shares of PACS Group stock. The stock was sold at an average price of $50.02, for a total value of $214,085.60.
- On Wednesday, October 28th, Mark Hancock sold 9,024 shares of PACS Group stock. The stock was sold at an average price of $50.10, for a total value of $452,102.40.
- On Tuesday, September 15th, Mark Hancock sold 155,682 shares of PACS Group stock. The stock was sold at an average price of $42.47, for a total value of $6,611,814.54.
- On Monday, September 14th, Mark Hancock sold 144,318 shares of PACS Group stock. The shares were sold at an average price of $44.57, for a total value of $6,432,253.26.
PACS Group Stock Up 8.5%
Shares of PACS Group stock traded up $3.95 on Wednesday, hitting $50.63. 1,790,293 shares of the company’s stock traded hands, compared to its average volume of 895,995. The stock has a market cap of $8.01 billion, a P/E ratio of 29.44, a PEG ratio of 1.42 and a beta of -0.14. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.21. The firm’s 50-day moving average is $44.29 and its 200 day moving average is $39.85. PACS Group, Inc. has a 52-week low of $10.31 and a 52-week high of $51.68.
PACS Group (NYSE:PACS – Get Free Report) last released its quarterly earnings results on Tuesday, November 3rd. The company reported $0.63 earnings per share for the quarter, topping analysts’ consensus estimates of $0.58 by $0.05. The business had revenue of $1.50 billion during the quarter, compared to the consensus estimate of $1.46 billion. PACS Group had a net margin of 4.85% and a return on equity of 29.55%. Equities analysts anticipate that PACS Group, Inc. will post 2.13 earnings per share for the current year.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently modified their holdings of the business. Nisa Investment Advisors LLC boosted its holdings in shares of PACS Group by 11.0% during the third quarter. Nisa Investment Advisors LLC now owns 2,327 shares of the company’s stock valued at $97,000 after acquiring an additional 230 shares during the period. Financial Management Professionals Inc. boosted its stake in PACS Group by 54.9% during the 2nd quarter. Financial Management Professionals Inc. now owns 663 shares of the company’s stock valued at $28,000 after purchasing an additional 235 shares during the period. Smith Group Asset Management LLC boosted its stake in PACS Group by 1.3% during the 3rd quarter. Smith Group Asset Management LLC now owns 24,680 shares of the company’s stock valued at $1,025,000 after purchasing an additional 320 shares during the period. Jacobsen Capital Management raised its holdings in shares of PACS Group by 3.4% during the third quarter. Jacobsen Capital Management now owns 17,837 shares of the company’s stock valued at $741,000 after buying an additional 579 shares during the last quarter. Finally, Toth Financial Advisory Corp boosted its position in shares of PACS Group by 87.5% during the third quarter. Toth Financial Advisory Corp now owns 1,500 shares of the company’s stock worth $62,000 after buying an additional 700 shares during the period.
Analysts Set New Price Targets
Several equities analysts have recently commented on PACS shares. Truist Financial set a $62.00 price target on shares of PACS Group in a research report on Wednesday, September 2nd. Royal Bank Of Canada boosted their price objective on PACS Group from $52.00 to $57.00 and gave the company an “outperform” rating in a report on Thursday, August 6th. UBS Group upped their price objective on PACS Group from $57.00 to $60.00 and gave the company a “buy” rating in a research note on Thursday, August 6th. Zacks Research downgraded PACS Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, September 9th. Finally, Wall Street Zen lowered PACS Group from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 8th. Five investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $58.80.
Get Our Latest Research Report on PACS
Trending Headlines about PACS Group
Here are the key news stories impacting PACS Group this week:
- Positive Sentiment: PACS reported third-quarter 2026 earnings of $0.63 per share, above estimates of $0.56–$0.58 and up from $0.32 a year earlier. Revenue of $1.50 billion also topped forecasts of $1.46 billion, supporting the positive market reaction. PACS Group, Inc. Reports Third Quarter 2026 Results PACS Group Q3 Earnings and Revenues Beat Estimates
- Negative Sentiment: CEO Jason Murray, director Mark Hancock, and chief accounting officer Michelle Lewis reported share sales. The sales could raise a modest concern about insider sentiment, but they were conducted under Rule 10b5-1 plans; Murray and Hancock continued to hold roughly 54 million shares each. CEO Form 4 filing Director Form 4 filing Chief accounting officer Form 4 filing
About PACS Group
PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.
The company’s operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.
Founded in 2013 and headquartered in Farmington, Utah, PACS Group serves communities across multiple U.S.
Recommended Stories
- Five stocks we like better than PACS Group
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.
